PUBLISHER: The Business Research Company | PRODUCT CODE: 2036102
PUBLISHER: The Business Research Company | PRODUCT CODE: 2036102
Single-cell expression quantitative trait locus (eQTL) clinical workflows are coordinated processes that examine gene expression variations at the single-cell level to identify eQTLs in clinical samples. These workflows integrate single-cell sequencing technologies with computational and statistical approaches to determine how genetic variants affect cellular transcription patterns. They provide detailed insights into disease mechanisms, facilitate biomarker discovery, and support personalized treatment strategies by linking genetic differences to functional cellular outcomes.
The key workflow types of single-cell expression quantitative trait locus (eQTL) clinical workflows include sample preparation, library preparation, sequencing, data analysis, and other workflow types. Sample preparation involves isolating and preparing individual cells for downstream molecular analysis. Technologies include ribonucleic acid sequencing, microarrays, polymerase chain reaction (PCR)-based methods, and other techniques. Applications cover disease research, drug discovery and development, personalized medicine, and other areas, serving hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and other end users.
Tariffs have affected the single-cell eQTL clinical workflow market by increasing the cost of importing sequencing instruments, reagents, and data analysis software. Segments such as sequencing technologies and library preparation are most impacted, particularly in regions like North America and Europe that rely on imported high-end equipment. Despite these challenges, tariffs are incentivizing local production and innovation, encouraging development of cost-efficient domestic solutions and enhancing supply chain resilience.
The single-cell expression quantitative trait locus (eQTL) clinical workflows market research report is one of a series of new reports from The Business Research Company that provides single-cell expression quantitative trait locus (eQTL) clinical workflows market statistics, including single-cell expression quantitative trait locus (eQTL) clinical workflows industry global market size, regional shares, competitors with a single-cell expression quantitative trait locus (eQTL) clinical workflows market share, detailed single-cell expression quantitative trait locus (eQTL) clinical workflows market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell expression quantitative trait locus (eQTL) clinical workflows industry. This single-cell expression quantitative trait locus (eQTL) clinical workflows market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The single-cell expression quantitative trait locus (eqtl) clinical workflows market size has grown rapidly in recent years. It will grow from $1.82 billion in 2025 to $2.18 billion in 2026 at a compound annual growth rate (CAGR) of 19.6%. The growth in the historic period can be attributed to adoption of bulk sequencing methods, rising investment in genomics research, increasing demand for disease biomarker identification, limited automation in workflows, reliance on manual data analysis.
The single-cell expression quantitative trait locus (eqtl) clinical workflows market size is expected to see rapid growth in the next few years. It will grow to $4.51 billion in 2030 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to growth of ai-driven analysis tools, adoption of single-cell sequencing technologies, expansion of personalized medicine initiatives, integration with cloud-based platforms, automation of sample and library preparation. Major trends in the forecast period include single-cell sequencing integration, advanced computational analysis, high-resolution gene expression mapping, automated workflow pipelines, predictive biomarker discovery.
The rising adoption of precision medicine is expected to propel the growth of the single-cell expression quantitative trait locus (eQTL) clinical workflows market going forward. Precision medicine is a medical approach that customizes disease prevention, diagnosis, and treatment strategies according to individual patient characteristics, including genetic makeup, lifestyle, and environment. The surge in precision medicine adoption is fueled by the growing global burden of complex and chronic diseases that require highly individualized treatment strategies. Single-cell expression quantitative trait locus (eQTL) clinical workflows support precision medicine by enabling high-resolution analysis of gene expression variations at the individual cell level, helping identify patient-specific therapeutic targets. They streamline genomic data processing and interpretation, shortening the time from sample collection to actionable insights, and enhancing personalized treatment strategies and clinical decision-making. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based educational and advocacy organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from 6 in 2022. Therefore, the growing adoption of precision medicine is driving the growth of the single-cell expression quantitative trait locus (eQTL) clinical workflows market.
Key companies operating in the single-cell expression quantitative trait locus (eQTL) clinical workflows market are focusing on developing innovative solutions, such as whole genome sequencing (WGS)-based eQTL workflow, to enable precise, cell-type-specific genetic analysis and advance personalized medicine. Whole genome sequencing (WGS)-based eQTL workflows are analytical approaches that integrate whole-genome sequencing data with gene expression data to identify genetic variants that regulate gene expression levels. For example, in January 2023, Singleron Biotechnologies Ltd., a Germany-based biotechnology company, launched a new single-cell eQTL analysis workflow as part of their sequencing service. It is a bioinformatic pipeline that leverages scRNA-seq and WGS data to predict cell-type-specific eQTLs, enabling researchers to investigate the association between genetic variation and gene expression levels at high resolution. This resource is ideal for customers conducting population studies and needing integrated wet lab and computational support, offering a streamlined solution to elucidate the molecular mechanisms of disease and complement Singleron's established single-cell multi-omics sequencing services.
In November 2025, QIAGEN N.V., a Netherlands-based biotechnology company, acquired Parse Biosciences Inc. for approximately $225 million. With this acquisition, QIAGEN plans to expand its sample technologies portfolio into highly scalable, instrument-free single-cell sequencing solutions, reinforcing its position in the fast-growing single-cell market and accelerating AI-driven biological research and drug discovery capabilities. Parse Biosciences Inc. is a US-based company providing single-cell RNA-seq solutions that deliver high-resolution expression data for cell-type-specific eQTL analysis in clinical research.
Major companies operating in the single-cell expression quantitative trait locus (eQTL) clinical workflows market are Thermo Fisher Scientific Inc., Becton Dickinson Company, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Genomics Co. Ltd., Novogene Co. Ltd., Takara Bio Inc., Standard BioTools Inc., Singleron Biotechnologies GmbH, Mission Bio Inc., Active Motif Inc., Admera Health LLC, Atrandi Biosciences UAB, SeqWell Inc., S2 Genomics Inc., Honeycomb Biotechnologies Inc., Roche Sequencing Solutions Inc., Cell Microsystems Inc.
North America was the largest region in the single-cell expression quantitative trait locus (eQTL) clinical workflows market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell expression quantitative trait locus (eQTL) clinical workflows market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the single-cell expression quantitative trait locus (eQTL) clinical workflows market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The single-cell expression quantitative trait locus (eQTL) clinical workflows market consists of revenues earned by entities by providing services such as integrated single-cell sequencing workflows, high-resolution gene expression analysis, computational eQTL mapping, and secure genomic data management. The market value includes the value of related goods sold by the service provider or included within the workflow offering. The single-cell expression quantitative trait locus (eQTL) clinical workflows market includes sales of single-cell library preparation kits, microfluidic consumables, sequencing reagents, cell isolation platforms, barcoding and indexing kits, and specialized bioinformatics software for eQTL analysis. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses single-cell expression quantitative trait locus (eqtl) clinical workflows market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for single-cell expression quantitative trait locus (eqtl) clinical workflows ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The single-cell expression quantitative trait locus (eqtl) clinical workflows market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.